Company Quick10K Filing
Musclepharm
10-K 2019-12-31 Filed 2020-08-25
10-Q 2019-09-30 Filed 2020-08-25
10-Q 2019-06-30 Filed 2020-08-25
10-Q 2019-03-31 Filed 2020-08-25
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-15
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-17
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-16
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-05
10-Q 2014-03-31 Filed 2014-05-05
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-24
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-16
10-Q 2011-03-31 Filed 2011-05-23
10-K 2010-12-31 Filed 2011-04-01
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-21
10-Q 2009-11-30 Filed 2010-01-11
8-K 2020-08-21 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2020-07-22 Officers
8-K 2020-05-14
8-K 2020-05-01
8-K 2020-04-20
8-K 2019-12-13
8-K 2019-10-04
8-K 2019-09-16
8-K 2019-06-06
8-K 2019-05-31
8-K 2019-04-30
8-K 2019-03-08
8-K 2018-12-07
8-K 2018-11-30
8-K 2018-11-13
8-K 2018-10-01
8-K 2018-09-04
8-K 2018-08-14
8-K 2018-05-14
8-K 2018-03-28
8-K 2018-02-26

Musclepharm Financials

MSLP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Madison Ventures (MDSV) -0.3 0 748 0 0 -327 -290 97
Vericity (VERY) 0% 5.7 -1% 806,697 498,016 70,671 0 -11,136 -11,400 -64,552
Anvi Global Holdings (ANVI) 0.3 -162% 139 1,059 0 0 -225 -225 -70
Cardinal Ethanol (CARD) 0% -3.1 -5% 137,552 25,273 260,669 36 -6,599 5,002 -15,308
Monitronics International (MTII) 54% -3.7 -33% 1,457,388 1,088,795 428,422 229,710 -473,690 -261,950 965,325
ECCO Auto World (ECCO) 100% 0.9 -42% 43 12 10 10 -18 -18 -16
Protective Life (PL) 0% -0.5 0% 119,751,045 110,460,110 5,735,562 0 383,675 544,873 -293,299
Everflow Eastern Partners (EEPL) 51% -4.2 6% 41,678 22,380 6,257 3,207 2,357 2,800 -11,649
Reva Medical (RVA) -33% -0.3 154% 10,626 83,896 265 -88 16,394 23,305 -7,094
Heyu Biological Technology (HEYU) 44% 1.3 -33% 1,079 1,699 57 25 -357 -357 -452
Fellazo (FLLC) 14.7 -0% 280 267 0 0 -0 -0 -3
Medixall Group (MDXL) 0% 0.0 -381% 559 362 2 0 -2,130 -2,130 -51
Ultimate Products (ULPC) 0.0 -1,320% 1 93 0 0 -10 -10 -0
Bankguam (BKGMF) -10.1 1% 1,951,731 1,790,610 0 0 12,309 18,839 -189,809
Morgan Stanley Smith Barney Spectrum Select (DWSF) -1.3 14% 32,102 876 0 0 4,606 4,606 -6,133
Trine Acquisition (TRNE) -0.2 1% 304,312 10,707 0 0 2,053 2,599 -588
Vaparia (VAPA) 0.1 -34% 220 832 0 0 -75 -75 -7
Peptide Technologies (PEPT) 0.0 -22% 251 672 0 0 -56 -57 -1
Scientific Energy (SCGY) 0.2 -253% 146 1,980 0 0 -369 -366 -86
Digital Brand Media & Marketing (DBMM) 10% -1.5 -567% 111 4,347 329 32 -627 -537 820

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash51866098,4838,6565,6845,4123,3163,7692,9501,0204,7844,1703,4577,0819,05413,0525,8944,9433,0163,5534,8786,2285,1142,4421,749
Accounts Receivable2,3993,6052,5693,3028,0289,23510,91113,74119,63419,19823,22016,64418,95924,60715,58622,00322,33920,21715,87213,35315,23613,40813,08716,66816,92516,27816,235
Inventory16,65419,76924,02721,06913,87214,85019,32012,5498,6136,9418,0478,5686,1146,1336,2746,4847,7387,6517,324
PP&E5149049082,0312,2462,3372,8553,9757,1288,2179,57010,43710,47911,09710,55110,65310,6987,9737,4937,3627,2587,1377,1466,6776,6936,7414,834
Assets4,8735,7175,0466,76720,53723,25141,54752,15865,61866,93379,61066,35667,90175,09162,24363,78161,23350,62738,33534,09631,10929,75430,11833,82633,89130,39728,348
Accounts Payable24,29123,90028,09727,76128,82637,83440,44239,65239,36539,09836,0939,62510,8919,1349,39711,74214,89716,56220,672
Long-Term Debt887933074,4687774702,5632,560468,0468,0463,8963,6003,26911,92211,69813,3485,99919,14618,43419,91921,85225,05424,46421,85819,320
Liabilities10,43410,85918,01716,52513,31010,64118,87332,42330,82028,83941,52142,97646,93256,92267,79273,84973,12165,63054,77538,97638,52539,76841,57646,36048,53246,01245,825
Stockholders' Equity-5,561-5,142-12,971-9,7587,22712,60922,67519,73534,79838,09338,08923,38020,96918,169-5,549-10,068-11,888-15,003-16,440-4,880-7,416-10,014-11,458-12,534-14,641-15,615-17,477
Income Statement ($'000)2011-06-302011-09-302011-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue3,8035,7567,76122,56125,48025,34437,49250,20971,60547,76832,67141,32250,47633,98241,07842,91232,86730,69426,02626,00926,19224,39625,55826,54727,10427,388
Cost of Revenue2,4823,8385,82714,39617,56717,93827,78532,33645,49232,81225,13826,93832,97823,51226,49927,69922,18120,49717,64919,53918,57616,35917,23618,32820,92118,595
Gross Profit1,3211,9181,9358,1657,9137,4069,70817,87326,11414,9577,53314,38417,49810,47014,57915,21310,68610,1978,3776,4707,6168,0378,3228,2198,3348,793
R&D1,0971,1647351,0019659211,437928863531270205137152199154212221185
SG&A3,2154,33112,7618,88610,6544,0435,8991,8722,3573,6525,4734,9625,1214,6474,6424,2434,4243,9373,3372,8862,8293,4682,8882,5462,6542,975
Tax00087834595-138402171113170180287624206934104
Net Income-7,437116-10,949-7,362-2,422-3,946-3,9882,7367,090603-16,236-7,479-7,025-27,648-9,706-6,605-4,196-1,4478,771-3,149-3,149-2,128-2,547-2,305-1,074-1,978
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-1,430-1,726-3,207-1,958-2,881-7851,325-6,0851,4126823,5073,520-2,2172,370-3,056200-14,582-1,042-775-520-2,794-2321932,062
Cash Investing-447-60-235-119-2,575-1,3031,619-3,8341,919-660-1,658-575-154-285,478-812600-27-10-14-59-13
Cash Financing1,3592,44611,9232,2452,496-3-2,5149,137-5,2273,822-2,366-3,7305,996-3641,584-7,26913,571-9001,3031,7374,296-872-2,795-2,726